Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology Drug Scaffolds. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering reliable pharmaceutical intermediate supply chain solutions.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for high-purity quinazolinone derivatives, offering significant supply chain advantages.